Pgi45 Work Productivity and Costs Related to Patients With Inflammatory Bowel Disease

Abstract

Objectives: Cost-effective screening strategies are needed to make Hepatitis C virus (HCV) elimination a reality. Our objective was to determine if birth cohort-based screening could be cost-effective in Italy. Methods: A Markov disease burden model was developed. An economic impact module was added to quantify medical costs and health effects associated with HCV infection. The cost-effectiveness threshold was set at V25,000. Modeled outcomes for disease burden, medical costs, and health effects of HCV infection were assessed under the status quo and as well as a scenario to achieve the WHO targets for eliminating HCV by 2030 under four screening strategies: